This review highlights the role of oxidative stress in endothelial progenitor cell dysfunction in type 1 diabetes, suggesting potential targets for EPC-based therapies.
No takes yet. Share an insight, caveat, or question.
Does not yet warrant clinical changes in type 1 diabetes; hypothesis-generating for antioxidant targeting of EPC dysfunction, needing prospective trials.
Loomans et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: